Table of contents
Volume 101, Issue 1
Published online 30 June 2009 (1-208)
Minireview
Early diagnosis of oesophageal cancer FREE
E L Bird-Lieberman and R C Fitzgerald
Br J Cancer 101: 1-6; advance online publication, June 9, 2009; doi:10.1038/sj.bjc.6605126
Clinical Studies
Prognosis and predictive value of KIT exon 11 deletion in GISTs
J-B Bachet, I Hostein, A Le Cesne, S Brahimi, A Beauchet, S Tabone-Eglinger, F Subra, B Bui, F Duffaud, P Terrier, J-M Coindre, J-Y Blay and J-F Emile
Br J Cancer 101: 7-11; advance online publication, June 16, 2009; doi:10.1038/sj.bjc.6605117
Cost-effectiveness analysis of XELOX for metastatic colorectal cancer based on the NO16966 and NO16967 trials
T Shiroiwa, T Fukuda and K Tsutani
Br J Cancer 101: 12-18; advance online publication, June 2, 2009; doi:10.1038/sj.bjc.6605114
High-intensity-focused ultrasound in the treatment of primary prostate cancer: the first UK series
H U Ahmed, E Zacharakis, T Dudderidge, J N Armitage, R Scott, J Calleary, R Illing, A Kirkham, A Freeman, C Ogden, C Allen and M Emberton
Br J Cancer 101: 19-26; advance online publication, June 9, 2009; doi:10.1038/sj.bjc.6605116
Patients with usual vulvar intraepithelial neoplasia-related vulvar cancer have an increased risk of cervical abnormalities
R P de Bie, H P van de Nieuwenhof, R L M Bekkers, W J G Melchers, A G Siebers, J Bulten, L F A G Massuger and J A de Hullu
Br J Cancer 101: 27-31; advance online publication, June 9, 2009; doi:10.1038/sj.bjc.6605124
Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases
S Armaou, M Pertesi, F Fostira, G Thodi, P S Athanasopoulos, S Kamakari, A Athanasiou, H Gogas, D Yannoukakos, G Fountzilas and I Konstantopoulou
Br J Cancer 101: 32-37; advance online publication, June 2, 2009; doi:10.1038/sj.bjc.6605115
Translational Therapeutics
Dasatinib synergizes with doxorubicin to block growth, migration, and invasion of breast cancer cells
C S Pichot, S M Hartig, L Xia, C Arvanitis, D Monisvais, F Y Lee, J A Frost and S J Corey
Br J Cancer 101: 38-47; advance online publication, June 9, 2009; doi:10.1038/sj.bjc.6605101
Quantitative immunohistochemical expression of c Kit in breast carcinomas is predictive of patients' outcome
C Charpin, S Giusiano, S Charfi, V Secq, S Carpentier, L Andrac, M-N Lavaut, C Allasia, P Bonnier and S Garcia
Br J Cancer 101: 48-54; advance online publication, June 9, 2009; doi:10.1038/sj.bjc.6605113
Preclinical efficacy of the bioreductive alkylating agent RH1 against paediatric tumours
D Hussein, S V Holt, K E Brookes, T Klymenko, J K Adamski, A Hogg, E J Estlin, T Ward, C Dive and G W J Makin
Br J Cancer 101: 55-63; advance online publication, June 2, 2009; doi:10.1038/sj.bjc.6605100
Angiogenesis and vascular network of teratocarcinoma from embryonic stem cell transplant into seminiferous tubules
U Silván, J Arlucea, R Andrade, A Díez-Torre, M Silió, M A Konerding and J Aréchaga
Br J Cancer 101: 64-70; advance online publication, June 9, 2009; doi:10.1038/sj.bjc.6605125
Fluorescent tumour imaging of type I IGF receptor in vivo: comparison of antibody-conjugated quantum dots and small-molecule fluorophore
H Zhang, X Zeng, Q Li, M Gaillard-Kelly, C R Wagner and D Yee
Br J Cancer 101: 71-79; advance online publication, June 2, 2009; doi:10.1038/sj.bjc.6605103
Molecular Diagnostics
Stable interference of EWS–FLI1 in an Ewing sarcoma cell line impairs IGF-1/IGF-1R signalling and reveals TOPK as a new target FREE
D Herrero-Martín, D Osuna, J L Ordóñez, V Sevillano, A S Martins, C Mackintosh, M Campos, J Madoz-Gúrpide, A P Otero-Motta, G Caballero, A T Amaral, D H Wai, Y Braun, M Eisenacher, K-L Schaefer, C Poremba and E de Alava
Br J Cancer 101: 80-90; advance online publication, June 2, 2009; doi:10.1038/sj.bjc.6605104
Abstract | Full Text | PDF | Supplementary information
Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer
D Öhlund, C Lundin, B Ardnor, M Öman, P Naredi and M Sund
Br J Cancer 101: 91-97; advance online publication, June 2, 2009; doi:10.1038/sj.bjc.6605107
UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer
M Unoki, J D Kelly, D E Neal, B A J Ponder, Y Nakamura and R Hamamoto
Br J Cancer 101: 98-105; advance online publication, June 2, 2009; doi:10.1038/sj.bjc.6605123
Expression of COX-2, NF-
B-p65, NF-B-p50 and IKK
in malignant and adjacent normal human colorectal tissue
M P Charalambous, T Lightfoot, V Speirs, K Horgan and N J Gooderham
Br J Cancer 101: 106-115; advance online publication, June 9, 2009; doi:10.1038/sj.bjc.6605120
High Ki67, Bax, and thymidylate synthase expression well correlates with response to chemoradiation therapy in locally advanced rectal cancers: proposal of a logistic model for prediction
M Kikuchi, T Mikami, T Sato, W Tokuyama, K Araki, M Watanabe, K Saigenji and I Okayasu
Br J Cancer 101: 116-123; advance online publication, June 2, 2009; doi:10.1038/sj.bjc.6605105
Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy
J Dunn, A Baborie, F Alam, K Joyce, M Moxham, R Sibson, D Crooks, D Husband, A Shenoy, A Brodbelt, H Wong, T Liloglou, B Haylock and C Walker
Br J Cancer 101: 124-131; advance online publication, June 16, 2009; doi:10.1038/sj.bjc.6605127
Death-associated protein 3 is overexpressed in human thyroid oncocytic tumours
C Jacques, J-F Fontaine, B Franc, D Mirebeau-Prunier, S Triau, F Savagner and Y Malthiery
Br J Cancer 101: 132-138; advance online publication, June 16, 2009; doi:10.1038/sj.bjc.6605111
Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer
R J Shaw, M M Omar, S Rokadiya, F A Kogera, D Lowe, G L Hall, J A Woolgar, J Homer, T Liloglou, J K Field and J M Risk
Br J Cancer 101: 139-144; doi:10.1038/sj.bjc.6605121
The oncogenic mutation in the pleckstrin homology domain of AKT1 in endometrial carcinomas
K Shoji, K Oda, S Nakagawa, S Hosokawa, G Nagae, Y Uehara, K Sone, Y Miyamoto, H Hiraike, O Hiraike-Wada, T Nei, K Kawana, H Kuramoto, H Aburatani, T Yano and Y Taketani
Br J Cancer 101: 145-148; advance online publication, June 2, 2009; doi:10.1038/sj.bjc.6605109
Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis
P de Graeff, A P G Crijns, S de Jong, M Boezen, W J Post, E G E de Vries, A G J van der Zee and G H de Bock
Br J Cancer 101: 149-159; advance online publication, June 9, 2009; doi:10.1038/sj.bjc.6605112
Serum oestrogen receptor and 
bioactivity are independently associated with breast cancer: a proof of principle study
M Widschwendter, H Lichtenberg-Frate, G Hasenbrink, S Schwarzer, A Dawnay, A Lam, U Menon, S Apostolidou, E Raum, C Stegmaier, I J Jacobs and H Brenner
Br J Cancer 101: 160-165; advance online publication, June 2, 2009; doi:10.1038/sj.bjc.6605106
Validation of UBE2C protein as a prognostic marker in node-positive breast cancer
D Loussouarn, L Campion, F Leclair, M Campone, C Charbonnel, G Ricolleau, W Gouraud, R Bataille and P Jézéquel
Br J Cancer 101: 166-173; advance online publication, June 9, 2009; doi:10.1038/sj.bjc.6605122
Epidemiology
Effectiveness of national cervical cancer screening programme in Taiwan: 12-year experiences
Y-Y Chen, S-L You, C-A Chen, L-Y Shih, S-L Koong, K-Y Chao, M-L Hsiao, C-Y Hsieh and C-J Chen and Taiwan Cervical Cancer Screening Task Force
Br J Cancer 101: 174-177; advance online publication, June 16, 2009; doi:10.1038/sj.bjc.6605139
Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial
L M Ferrucci, A J Cross, B I Graubard, L A Brinton, C A McCarty, R G Ziegler, X Ma, S T Mayne and R Sinha
Br J Cancer 101: 178-184; advance online publication, June 9, 2009; doi:10.1038/sj.bjc.6605118
Urinary phytoestrogen excretion and prostate cancer risk: a nested case–control study in the Multiethnic Cohort
S-Y Park, L R Wilkens, A A Franke, L Le Marchand, K K Kakazu, M T Goodman, S P Murphy, B E Henderson and L N Kolonel
Br J Cancer 101: 185-191; advance online publication, June 16, 2009; doi:10.1038/sj.bjc.6605137
Cancer incidence in British vegetarians FREE
T J Key, P N Appleby, E A Spencer, R C Travis, N E Allen, M Thorogood and J I Mann
Br J Cancer 101: 192-197; advance online publication, June 16, 2009; doi:10.1038/sj.bjc.6605098
Suicide in cancer patients in South East England from 1996 to 2005: a population-based study
D Robinson, C Renshaw, C Okello, H Møller and E A Davies
Br J Cancer 101: 198-201; advance online publication, May 26, 2009; doi:10.1038/sj.bjc.6605110
HPV infection in women with and without cervical cancer in Conakry, Guinea
N Keita, G M Clifford, M Koulibaly, K Douno, I Kabba, M Haba, B S Sylla, F J van Kemenade, P J F Snijders, C J L M Meijer and S Franceschi
Br J Cancer 101: 202-208; advance online publication, June 16, 2009; doi:10.1038/sj.bjc.6605140
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
